NDRA (ENDRA Life Sciences) FCF Margin %: 0.00% (As of Mar. 2026)


NDRA ENDRA Life Sciences Inc NDRA
25 GF Score
Price $4.30
! 2 Warning Signs
View Full Analysis

What is ENDRA Life Sciences FCF Margin %?

ENDRA Life Sciences NDRA -31.42% 25 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates NDRA with a GF Score™ of 25/100. The stock has 2 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, ENDRA Life Sciences ranks worse than 490195.59% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. ENDRA Life Sciences's Free Cash Flow for the three months ended in Mar. 2026 was $-1.12 Mil. ENDRA Life Sciences's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, ENDRA Life Sciences's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, ENDRA Life Sciences's current FCF Yield % is -91.76%.

The historical rank and industry rank for ENDRA Life Sciences's FCF Margin % or its related term are showing as below:


During the past 12 years, the highest FCF Margin % of ENDRA Life Sciences was -255.04%. The lowest was -130033.33%. And the median was -940.06%.

NDRA's FCF Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -1.845
* Ranked among companies with meaningful FCF Margin % only.

ENDRA Life Sciences FCF Margin % Related Terms

ENDRA Life Sciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for ENDRA Life Sciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ENDRA Life Sciences FCF Margin % Chart

ENDRA Life Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ENDRA Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NDRA vs NOTV, XWEL, ADVB: FCF Margin % Comparison

For the Diagnostics & Research subindustry, ENDRA Life Sciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ENDRA Life Sciences FCF Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, ENDRA Life Sciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where ENDRA Life Sciences's FCF Margin % falls into.


NDRA
25GF Score
ENDRA Life Sciences Inc NDRA
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ENDRA Life Sciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

ENDRA Life Sciences's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-8.2/0
= %

ENDRA Life Sciences's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-1.12/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
ENDRA Life Sciences (NDRA) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on ENDRA Life Sciences and its competitors. According to the industry distribution chart, ENDRA Life Sciences ranks #999999 out of 204 companies in the Medical Diagnostics & Research industry.
Is ENDRA Life Sciences' FCF Margin % too high?
ENDRA Life Sciences' current FCF Margin % is 0.00%. Based on the distribution chart, ENDRA Life Sciences ranks #999999 out of 204 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, ENDRA Life Sciences has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does ENDRA Life Sciences' FCF Margin % compare to NOTV and XWEL?
According to the Medical Diagnostics & Research industry distribution chart, ENDRA Life Sciences ranks #999999 out of 204 companies for FCF Margin %. This places ENDRA Life Sciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on ENDRA Life Sciences and its competitors. ENDRA Life Sciences's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ENDRA Life Sciences stock overvalued right now?
ENDRA Life Sciences (NDRA) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. ENDRA Life Sciences' overall GF Score™ is 25/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For ENDRA Life Sciences (NDRA), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ENDRA Life Sciences Business Description

Address 3600 Green Court, Suite 350, Ann Arbor, MI, USA, 48105-1570
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.
25GF Score

Get the complete analysis for NDRA

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.30
Price